Percentage of patients found with a kidney function too low for recommended use of the drug using estimated glomerular filtration rate compared with creatinine.

Slides:

Advertisements

Similar presentations

Mugendi AG, BPharm, MPharm (Clin Pharm). Comparison of the effects of losartan and enalapril on renal function in adults with chronic kidney disease at.

Advertisements

Section V. Assessment for Renovascular Hypertension 2015 Canadian Hypertension Education Program Recommendations.

Trends and inequities in beta-blocker prescribing for heart failure by Sunil M Shah, Iain M Carey, Stephen DeWilde, Nicky Richards, and Derek G Cook BJGP.

Systemic Implementation Strategies to Improve Hypertension: The Kaiser Permanente Southern California Experience John J. Sim, MD, Joel Handler, MD, Steven.

FIGURE 1 Flow chart of the study population

Copyright © 2006 American Medical Association. All rights reserved.

Figure 1. Serum creatinine trend in the patient

Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.

Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and.

Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician Joseph A. Vassalotti, MD, Robert Centor, MD,

Sumeska Thavarajah, MD, Daphne H. Knicely, MD, Michael J. Choi, MD

Improving Transitions in CKD: Failure Mode

Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias Jorge E. Cortes, Carlo Gambacorti-Passerini,

Thinking Beyond New Clinical Guidelines: Update in Hypertension

Psychotropic drug use among older people in general practice: discrepancies between opinion and practice by Andrea Lasserre, Nadia Younès, Thierry Blanchon,

The dangers of NSAIDs: look both ways

Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus George L. Bakris, MD Mayo Clinic.

Manish M. Sood, MD, Amy R. Sood, Robert Richardson, MD

Nat. Rev. Nephrol. doi: /nrneph

Addison’s disease: identification and management in primary care

Fig. 2. Evidence-based medication prescriptions

Nat. Rev. Cardiol. doi: /nrcardio

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Prevalence of primary aldosteronism in primary care: a cross-sectional study by Sabine C Käyser, Jaap Deinum, Wim JC de Grauw, Bianca WM Schalk, Hans JHJ.

Effectiveness of diclofenac versus paracetamol in knee osteoarthritis: a randomised controlled trial in primary care by Saskia PJ Verkleij, Pim AJ Luijsterburg,

Run chart displaying weekly data on patient understanding of the non-steroidal anti-inflammatory drugs (NSAIDs) messages after the NSAIDs bundle package.

Elbow pain: a guide to assessment and management in primary care

Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care by Jennifer A Hirst, Maria.

Volume 84, Issue 1, Pages (July 2013)

Steven J. Rosansky, Richard J. Glassock Kidney International

by Nicola Adderley, Ronan Ryan, and Tom Marshall

Developing patient reference groups within general practice: a mixed-methods study by Jane Smiddy, Joanne Reay, Stephen Peckham, Lorraine Williams, and.

Clinical features of bladder cancer in primary care

by Sally Hull, Rohini Mathur, Gavin Dreyer, and Muhammad Magdi Yaqoob

Evaluation of a complex intervention to improve primary care prescribing: a phase IV segmented regression interrupted time series analysis by Sean MacBride-Stewart,

GPs' classification of headache: is primary headache underdiagnosed?

by Simon DS Fraser, Paul J Roderick, and Maarten W Taal

Clinical features of kidney cancer in primary care: a case-control study using primary care records by Elizabeth Shephard, Richard Neal, Peter Rose, Fiona.

Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care by Jennifer A Hirst, Maria.

Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.

by Ali Albasri, Suman Prinjha, Richard J McManus, and James P Sheppard

Evaluation of a complex intervention to improve primary care prescribing: a phase IV segmented regression interrupted time series analysis by Sean MacBride-Stewart,

(A) 1-year mortality in relation to estimated glomerular filtration rate (eGFR), age (n=47 636) and presence of diabetes mellitus (n=47 624). (A) 1-year.

Rami Doukky et al. JCHF 2016;4:24-35

Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W

by Ali Albasri, Suman Prinjha, Richard J McManus, and James P Sheppard

Out-of-hours primary care use at the end of life: a descriptive study

Trends and inequities in beta-blocker prescribing for heart failure

(A) Mortality in patients with heart failure and different estimated glomerular filtration rate (eGFR) strata, crude survival assessed by Kaplan-Meier.

by Melanie J Calvert, Richard J McManus, and Nick Freemantle

Volume 81, Issue 7, Pages (April 2012)

Volume 73, Issue 5, Pages (March 2008)

Volume 81, Issue 12, Pages (June 2012)

High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study by Aafke R Koffeman, Vera E Valkhoff,

Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review by Hugh Gallagher, Simon.

Unadjusted odds ratio of death at 6 mo for medications (β blockers [BBL], angiotensin-converting enzyme inhibitors [ACEI]/angiotensin receptor blockers.

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

Combination angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) reduced risk for renal end point versus ACEI or ARB. Effect.

An updated general approach for achieving BP goals in people with diabetes. An updated general approach for achieving BP goals in people with diabetes.

by Marion Murphy, Stephen Byrne, and Colin P Bradley

Effect of methylprednisolone versus placebo on the risk of acute kidney injury: subgroup analysis by preoperative chronic kidney disease. Effect of methylprednisolone.

Dot plots comparing changes in renal function at pretreatment and after the first and last cycles in both hydration groups. Dot plots comparing changes.

Sumeska Thavarajah, MD, Daphne H. Knicely, MD, Michael J. Choi, MD

Incidence and recurrence of boils and abscesses within the first year: a cohort study in UK primary care by Laura J Shallcross, Andrew C Hayward, Anne.

Prevalence of regular non-steroidal anti-inflammatory drug (NSAID) use by age and race/ethnicity. Prevalence of regular non-steroidal anti-inflammatory.

Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.

Quality improvement of prescribing safety: a pilot study in primary care using UK electronic health records by Helen P Booth, Arlene M Gallagher, David.

Trends in the epidemiology of smoking recorded in UK general practice

Presentation transcript:

Percentage of patients found with a kidney function too low for recommended use of the drug using estimated glomerular filtration rate compared with creatinine clearance (Cockcroft–Gault) in the three older age bands. Percentage of patients found with a kidney function too low for recommended use of the drug using estimated glomerular filtration rate compared with creatinine clearance (Cockcroft–Gault) in the three older age bands. ACEIs = angiotensin-converting enzyme inhibitor. ARBs = angiotensin II receptor blockers. CrCI = creatinine clearance. eGFR = estimated glomerular filtration rate. NSAIDs = non-steroidal anti-inflammatory drugs. Su Wood et al. Br J Gen Pract 2018;68:e378-e387 ©2018 by British Journal of General Practice